Ajjai Alva Profile | University of Michigan

Dr. Ajjai Alva, M.D.

Claim this profile

University of Michigan Comprehensive Cancer Center

Studies Renal Cell Carcinoma
Studies Kidney Cancer
7 reported clinical trials
41 drugs studied

Area of expertise

1Renal Cell Carcinoma
Ajjai Alva, M.D. has run 4 trials for Renal Cell Carcinoma. Some of their research focus areas include:
VEGF
VEGFR
anti-VEGF inhibitor
2Kidney Cancer
Ajjai Alva, M.D. has run 4 trials for Kidney Cancer. Some of their research focus areas include:
VEGF
VEGFR
anti-VEGF inhibitor

Affiliated Hospitals

Image of trial facility.
University Of Michigan Comprehensive Cancer Center
Image of trial facility.
University Of Michigan

Clinical Trials Ajjai Alva, M.D. is currently running

Image of trial facility.

Targeted Therapy

for Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria

More about Ajjai Alva, M.D.

Clinical Trial Related10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Ajjai Alva, M.D. has experience with
  • Afatinib
  • Larotrectinib
  • Pembrolizumab
  • Nivolumab
  • TAK-228
  • Abemaciclib
Breakdown of trials Ajjai Alva, M.D. has run
Renal Cell Carcinoma
Kidney Cancer
Cancer
Solid Tumors
Pancreatic Cancer

Other Doctors you might be interested in

Elena Stoffel, MDUniversity of Michigan
Matthew Romano, MDUniversity of Michigan
Abbas Bitar, MDUniversity of Michigan

Frequently asked questions

Do I need insurance to participate in a trial?
What does Ajjai Alva, M.D. specialize in?
Is Ajjai Alva, M.D. currently recruiting for clinical trials?
Are there any treatments that Ajjai Alva, M.D. has studied deeply?
What is the best way to schedule an appointment with Ajjai Alva, M.D.?
What is the office address of Ajjai Alva, M.D.?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security